A detailed history of Hbk Sorce Advisory LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Hbk Sorce Advisory LLC holds 49,331 shares of MRK stock, worth $4.91 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares
49,331
Previous 49,727 0.8%
Holding current value
$4.91 Million
Previous $6.16 Million 9.0%
% of portfolio
0.22%
Previous 0.23%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$111.15 - $128.97 $44,015 - $51,072
-396 Reduced 0.8%
49,331 $5.6 Million
Q2 2024

Aug 08, 2024

SELL
$123.8 - $132.96 $57,938 - $62,225
-468 Reduced 0.93%
49,727 $6.16 Million
Q1 2024

May 09, 2024

BUY
$113.24 - $131.95 $106,219 - $123,769
938 Added 1.9%
50,195 $6.62 Million
Q4 2023

Jan 25, 2024

SELL
$100.18 - $109.02 $294,328 - $320,300
-2,938 Reduced 5.63%
49,257 $5.37 Million
Q3 2023

Nov 06, 2023

BUY
$102.95 - $114.33 $823 - $914
8 Added 0.02%
52,195 $5.37 Million
Q2 2023

Aug 04, 2023

SELL
$108.61 - $118.38 $5.9 Million - $6.43 Million
-54,307 Reduced 51.0%
52,187 $6.02 Million
Q1 2023

Aug 15, 2023

BUY
$102.94 - $114.86 $184,777 - $206,173
1,795 Added 3.44%
53,982 $5.74 Million
Q1 2023

May 15, 2023

SELL
$102.94 - $114.86 $752,903 - $840,086
-7,314 Reduced 6.43%
106,494 $17 Million
Q4 2022

Feb 09, 2023

BUY
$87.44 - $112.11 $5.32 Million - $6.82 Million
60,877 Added 115.01%
113,808 $12.6 Million
Q3 2022

Nov 14, 2022

BUY
$84.53 - $94.96 $568,886 - $639,080
6,730 Added 14.57%
52,931 $4.56 Million
Q2 2022

Aug 15, 2022

SELL
$83.49 - $94.64 $853,017 - $966,936
-10,217 Reduced 18.11%
46,201 $4.21 Million
Q1 2022

May 13, 2022

SELL
$73.51 - $82.4 $302,346 - $338,911
-4,113 Reduced 6.79%
56,418 $4.63 Million
Q4 2021

Feb 15, 2022

SELL
$72.28 - $90.54 $549,978 - $688,918
-7,609 Reduced 11.17%
60,531 $4.64 Million
Q3 2021

Nov 15, 2021

BUY
$71.68 - $78.83 $218,337 - $240,116
3,046 Added 4.68%
68,140 $5.12 Million
Q2 2021

Aug 12, 2021

BUY
$70.31 - $77.77 $337,909 - $373,762
4,806 Added 7.97%
65,094 $5.06 Million
Q1 2021

May 14, 2021

BUY
$68.86 - $81.11 $109,625 - $129,127
1,592 Added 2.71%
60,288 $4.65 Million
Q4 2020

Feb 12, 2021

BUY
$71.77 - $79.65 $46,865 - $52,011
653 Added 1.13%
58,696 $4.8 Million
Q3 2020

Nov 13, 2020

SELL
$73.18 - $82.95 $33,370 - $37,825
-456 Reduced 0.78%
58,043 $4.82 Million
Q2 2020

Aug 14, 2020

BUY
$70.42 - $80.13 $405,689 - $461,628
5,761 Added 10.92%
58,499 $4.52 Million
Q1 2020

May 15, 2020

BUY
$63.36 - $87.82 $141,609 - $196,277
2,235 Added 4.43%
52,738 $4.06 Million
Q4 2019

Feb 13, 2020

BUY
$77.58 - $87.54 $83,165 - $93,842
1,072 Added 2.17%
50,503 $4.59 Million
Q3 2019

Nov 14, 2019

BUY
$76.08 - $82.93 $64,972 - $70,822
854 Added 1.76%
49,431 $4.16 Million
Q2 2019

Aug 15, 2019

BUY
$69.84 - $81.59 $2.64 Million - $3.08 Million
37,756 Added 348.91%
48,577 $4.07 Million
Q2 2019

Aug 14, 2019

SELL
$69.84 - $81.59 $2.39 Million - $2.8 Million
-34,273 Reduced 76.0%
10,821 $623,000
Q1 2019

May 13, 2019

BUY
$69.58 - $79.36 $57,890 - $66,027
832 Added 1.88%
45,094 $3.75 Million
Q4 2018

Feb 14, 2019

SELL
$65.24 - $75.71 $82,985 - $96,303
-1,272 Reduced 2.79%
44,262 $3.38 Million
Q3 2018

Nov 15, 2018

BUY
$57.69 - $67.84 $20,479 - $24,083
355 Added 0.79%
45,534 $3.23 Million
Q2 2018

Aug 10, 2018

SELL
$50.83 - $59.72 $16,316 - $19,170
-321 Reduced 0.71%
45,179 $0
Q1 2018

May 15, 2018

SELL
$50.96 - $59.23 $52,437 - $60,947
-1,029 Reduced 2.21%
45,500 $2.48 Million
Q4 2017

Feb 15, 2018

BUY
$51.62 - $61.64 $1.4 Million - $1.67 Million
27,102 Added 139.51%
46,529 $2.62 Million
Q3 2017

Nov 14, 2017

BUY
$58.67 - $63.13 $1.14 Million - $1.23 Million
19,427
19,427 $1.24 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $252B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Hbk Sorce Advisory LLC Portfolio

Follow Hbk Sorce Advisory LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hbk Sorce Advisory LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hbk Sorce Advisory LLC with notifications on news.